Browsing Tag
Bylvay
2 posts
Ipsen stock edges higher as Japan clears Bylvay for rare liver disease — is the upside real for investors?
Ipsen (IPN) gains after Japan approves Bylvay for rare liver disease. See stock performance, analyst sentiment, and whether it’s time to buy, hold, or sell.
Ipsen gets Bylvay FDA approval for cholestatic pruritus in Alagille syndrome
The US Food and Drug Administration (FDA) has granted approval to French biopharmaceutical company Ipsen for Bylvay (odevixibat)…